排序方式: 共有58条查询结果,搜索用时 0 毫秒
1.
分水岭脑梗死是临床脑梗死中的常见类型。随着人们对于分水岭脑梗死研究的进一步加深,分水岭脑梗死的中医药研究方面同时也取得了很大的进展。此文尝试从分水岭脑梗死的中医病因病机、体质分型、辨证论治、中成药的治疗、针灸治疗等方面对分水岭脑梗死的中医药研究进展进行综合论述,为分水岭脑梗死的临床治疗提供理论依据。 相似文献
2.
中风病是临床的常见病、多发病。本病病因较多,病情变化迅速,证型繁杂,不同的文献中证候分类差异较大。证候分类的繁杂给临床工作者治疗中风病带来极大不便。本文对以证候要素(内风、内火、痰湿、瘀血、气虚、阴虚)为切入点论治中风病的理论进行探讨,并举例论证其临床疗效。 相似文献
3.
难治性癫痫(RE)病机复杂,易于反复,朱文浩主任医师注重情志内伤对RE患者体质的影响,在治疗上重视“脏气不平”这一发病基础,从“气郁血瘀”角度分析,以血府逐瘀汤为基础方进行治疗,临床上取得满意疗效。该文选取2则医案进行深入分析。 相似文献
4.
5.
6.
7.
目的探讨吸烟与中风病中医证候的相关性。方法制定调查表,由临床中医师采集中风病患者的临床资料并辨证,然后双人、双盲录入到数据库,导出数据后统计分析。将中风病患者分为吸烟组和非吸烟组,分别对两组的中医证候进行统计分析。结果吸烟组中风病患者年龄(64.7±0.7)岁,小于非吸烟组(69.5±0.5)岁,吸烟组中风病患者风痰阻络证的比例(61.4%),高于非吸烟组(51.9%)。结论吸烟使中风病的发病年龄提前,与中风病风痰阻络证的形成有关。 相似文献
8.
The study aimed to investigate the impact of intraclot recombinant tissue-type plasminogen activator (rt-PA) on perihematomal edema (PHE) development in patients with intracerebral hemorrhage (ICH) treated with minimally invasive surgery (MIS) and the effects of intraclot rt-PA on the 30-day survival. We reviewed the medical records of ICH patients undergoing MIS between October 2011 and July 2013. A volumetric analysis was done to assess the change in PHE and ICH volumes at pre-MIS (T1), post-MIS (T2) and day 10-16 (T3) following diagnostic computed tomographic scans (To). Forty-three patients aged 52.8±11.1 years with (n=30) or without rt-PA (n=13) were enrolled from our institutional ICH database. The median rt-PA dose was 1.5 (1) mg, with a maximum dose of 4.0 mg. The ratio of clot evacuation was significantly increased by intraclot rt-PA as compared with controls (77.9%±20.4% vs. 64%±15%; P=0.046). From TI to T2, reduction in PHE volume was strongly associ- ated with the percentage of clot evacuation (p=0.34; P=-0.027). In addition, PHE volume was positively correlated with residual ICH volume at the same day (p ranging from 0.39-0.56, P〈0.01). There was no correlation between the cumulative dose of rt-PA and early (T2) PHE volume (p=0.24; P=0.12) or de- layed (T3) PHE volume (p=0.19; P=0.16). The 30-day mortality was zero in this cohort. In the selected cohort of ICH patients treated with MIS, intraclot rt-PA accelerated clot removal and had no effects on PHE formation. MIS aspiration and low dose of rt-PA seemed to be feasible to reduce the 30-day mor- tality in patients with severe ICH. A large, randomized study addressing dose titration and long-term outcome is needed. 相似文献
9.
目的:了解脑出血微创血肿抽吸引流术(微创术)后颅内积气的发生情况。方法:接受微创术治疗的脑出血患者134例,术后出现颅内积气的患者为A组(n=97),未出现颅内积气的病例为B组(n=37)。对2组的临床数据进行统计分析。结果:A组中双针穿刺比例、血肿抽吸量及引流量与B组比较差异有统计学意义(P<0.05)。Logistic回归分析表明,双针穿刺是影响术后颅内积气及其严重程度的独立危险因素。结论:脑出血微创血肿抽吸引流术后常出现颅内积气,但对患者预后无显著影响。双针穿刺可能增加术后颅内积气的风险。 相似文献
10.
目的分析总结恢刺法的临床应用特点。方法分别以《中华医典》和中国知网(CNKI)为数据库,检索古代文献、现代文献中运用恢刺法治疗疾病的内容,对恢刺法临床应用的相关情况进行总结。结果共纳入古代文献12篇、现代文献31篇。古代文献中恢刺法的临床应用以筋痹为主要适应症,从受损肌腱旁斜刺进针,进针后,提插行针并调整针灸针,再将针提至皮下,配合关节屈伸活动,以舒解筋部拘挛。现代文献中恢刺法的临床应用以治疗关节及其周围软组织局部的劳损性病变为主;选穴以阿是穴为主,有时配合局部取穴及循经取穴;选用直刺进针法者较多,多数使用平补平泻或泻法,最短留针时间为10min,最长留针时间为2h;常用的配合治疗手段有其他种类刺法、灸法、拔罐法、腧穴特种治疗技术及其他方法,如推拿、梅花针、头皮针。结论恢刺法现代临床应用基本沿袭了古代恢刺法的应用特点,恢刺法的操作技法得到了较好的传承,后人在前辈的基础上扩大了其适应症,临床应用效果较好。 相似文献